John M Lepi, MD | |
945 Bethesda Dr, Suite 120, Zanesville, OH 43701-0801 | |
(740) 452-6778 | |
(740) 454-4770 |
Full Name | John M Lepi |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 34 Years |
Location | 945 Bethesda Dr, Zanesville, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497855027 | NPI | - | NPPES |
0893387 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 35-062044 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Genesis Hospital | Zanesville, OH | Hospital |
Southeastern Ohio Regional Medical Center | Cambridge, OH | Hospital |
Entity Name | John M Lepi Md Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104129584 PECOS PAC ID: 7113114778 Enrollment ID: O20101208000470 |
News Archive
The scientific tools are not yet available to build a comprehensive map of the activity in the most complicated 3 pounds of material in the world - the human brain, scientists say in a newly published article.
Cancer starts when key cellular signals run amok, driving uncontrolled cell growth. But scientists at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in mice, returning tumor cells to their normal, healthy state. The finding could help target cancer chemotherapy to tumors while minimizing side effects for the body's healthy cells.
A pioneering study reports on the interaction of a tailored titanium oxide nanoparticle (NP) with the full-length SARS-CoV-2 non-structural protein 1 (nsp1). This should be of value in developing new therapeutic tools against coronaviruses that act by targeting their proteins. It could also help map the structure of activated proteins.
Septic shock is the most severe outcome associated with pathogen infection in the bloodstream. It is a life-threatening condition invariably leading to multiple organ dysfunctions. Currently, septic shock is one of the most frequent causes of death in intensive care units worldwide.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the Schepens Eye Research Institute, a charitable corporation of Massachusetts and an affiliate of Harvard Medical School.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
John M Lepi, MD 945 Bethesda Dr, Suite 120, Zanesville, OH 43701-0801 Ph: (740) 452-6778 | John M Lepi, MD 945 Bethesda Dr, Suite 120, Zanesville, OH 43701-0801 Ph: (740) 452-6778 |
News Archive
The scientific tools are not yet available to build a comprehensive map of the activity in the most complicated 3 pounds of material in the world - the human brain, scientists say in a newly published article.
Cancer starts when key cellular signals run amok, driving uncontrolled cell growth. But scientists at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in mice, returning tumor cells to their normal, healthy state. The finding could help target cancer chemotherapy to tumors while minimizing side effects for the body's healthy cells.
A pioneering study reports on the interaction of a tailored titanium oxide nanoparticle (NP) with the full-length SARS-CoV-2 non-structural protein 1 (nsp1). This should be of value in developing new therapeutic tools against coronaviruses that act by targeting their proteins. It could also help map the structure of activated proteins.
Septic shock is the most severe outcome associated with pathogen infection in the bloodstream. It is a life-threatening condition invariably leading to multiple organ dysfunctions. Currently, septic shock is one of the most frequent causes of death in intensive care units worldwide.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the Schepens Eye Research Institute, a charitable corporation of Massachusetts and an affiliate of Harvard Medical School.
› Verified 5 days ago
Dr. Jessica Martin Lafyatis, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr Ste 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Mitesh H. Parekh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1210 Ashland Ave, Zanesville, OH 43701 Phone: 740-454-8551 | |
Dr. Callie Elyse Crider, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr Ste 330, Zanesville, OH 43701 Phone: 750-454-8800 | |
Dr. Kristy L Ritchie, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr, Ste 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Linda T Swan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 945 Bethesda Drive, Suite 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Kristina L Loomis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Drive, Suite 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 |